D2R | DNA to RNA - McGill University

Main navigation

D2R News

Stay informed about D2R updates by subscribing to our mailing list!

DNA to RNA (D2R)

An inclusive Canadian approach to genomic-based RNA therapeutics

The time is now for discovery and development of genome-guided, RNA-based precision medicines for Canada and for the world. With a landmark $165 million investment from the Canada First Research Excellence Fund, McGill’s world-leading research initiative DNA to RNA (D2R) will develop revolutionary genomic-based RNA medicines for all people of Canada.

Discover the initiative

women in a lab coat conducting tests in a lab

Open funding opportunities

Major Partnerships

Facilitating engagement of external partners.

Commercialization Priming

Supporting early-stage efforts that test or validate the commercial potential.

Postdoctoral Scholar Awards

Supporting postdoctoral researchers through funding and training.

View D2R funding opportunities

Meet D2R Researchers

Curious about the research supported by D2R? Watch the videos below of D2R-funded researchers sharing insights into their projects and what drives their passion for research.

D2R represents a unique constellation of outstanding and internationally recognized experts working together across Canada to drive D2R’s outcome-driven initiative

The D2R Network